A patent has been granted in the US covering the use of Neurizon’s lead drug candidate NUZ-001 in neurodegenerative diseases ...

AstraZeneca has launched new lawsuits against four generic drug ... patents over Lynparza and that AstraZeneca’s claims are invalid. The drugmakers are requesting a “judicial declaration ...

Neurizon (ASX:NUZ) has officially snagged a U.S. patent for its neurodegenerative disease and cancer drug candidate NUZ-001, ...

The use of march-in rights to target pricy drugs has been a controversial issue across several administrations.

has filed a divisional patent application with the Israel Patent Office for its Trap & Target or T&T intranasal drug delivery platform. The T&T platform is designed to enhance the bioavailability ...

Cristina Brennan can hear the clock ticking. At the end of the year, her 12-year-old son Tristan will no longer have free ...

The U.S. Supreme Court has once again been urged to revisit 35 U.S.C. § 101, the statute governing patent eligibility. Audio ...

The divisional patent application underscores Polyrizon’s commitment to securing comprehensive intellectual property protection for its innovative technology, which aim to revolutionize respiratory ...

While 118 biologics are expected to lose patent protection in the US over the next decade, that $234 billion opportunity for ...

(Reginald Dwayne Betts, Titus Kaphar). Check out all installments in the OppArt series. Reginald Dwayne Betts and Titis KapharThe artists worked with members of Mural Arts’ Guild Program, a re ...

There's a simple way to find out when your money will come -- you can use the IRS tool that lets you see the status of your tax refund. We'll explain how to track the status of your refund and any ...

On January 14, 2025, the United States Court of Appeals for the Federal Circuit (“CAFC”) issued a precedential opinion affirming a final ...